<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Friligkou E</submitter><funding>One Mind</funding><funding>NIMH NIH HHS</funding><pagination>e145</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12094657</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>55</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>To understand the pathogenetic mechanisms shared among schizophrenia (SCZ), bipolar disorder (BP), and major depression (MDD), we investigated the pleiotropic mechanisms using large-scale genome-wide and brain transcriptomic data.&lt;h4>Methods&lt;/h4>We analyzed SCZ, BP, and MDD genome-wide association datasets available from the Psychiatric Genomics Consortium using the PLEIO framework and characterized the pleiotropic loci identified using pathway and tissue enrichment analyses. Pleiotropic and disorder-specific loci were also assessed.&lt;h4>Results&lt;/h4>Our pleiotropy-informed genome-wide analysis identified 553 variants that included 192 loci not reaching genome-wide significance in input datasets. These were enriched for five molecular pathways: cadherin signaling (&lt;i>p&lt;/i> = 2.18 × 10&lt;sup>-8&lt;/sup>), Alzheimer's disease-amyloid secretase (&lt;i>p&lt;/i> = 4 × 10&lt;sup>-4&lt;/sup>), oxytocin receptor-mediated signaling (&lt;i>p&lt;/i> = 1.47 × 10&lt;sup>-3&lt;/sup>), metabotropic glutamate receptor group III (&lt;i>p&lt;/i&gt; = 5.82 × 10&lt;sup>-4&lt;/sup>) and Wnt signaling (&lt;i>p&lt;/i> = 1.61 × 10&lt;sup>-11&lt;/sup>). Pleiotropic loci demonstrated the strongest enrichment in the brain cortex (&lt;i>p&lt;/i> = 5.8 × 10&lt;sup>-28&lt;/sup>), frontal cortex (&lt;i>p&lt;/i> = 3 × 10&lt;sup>-31&lt;/sup>), and cerebellar hemisphere (&lt;i>p&lt;/i> = 9.8 × 10&lt;sup>-28&lt;/sup>). SCZ-BP-MDD pleiotropic variants were also enriched for neurodevelopmental brain transcriptomic profiles related to the second-trimester post-conception (week 21, &lt;i>p&lt;/i> = 7.35 × 10&lt;sup>-5&lt;/sup>; week 17, &lt;i>p&lt;/i> = 6.36 × 10&lt;sup>-4&lt;/sup>) and first year of life (&lt;i>p&lt;/i> = 3.25 × 10&lt;sup>-5&lt;/sup>).&lt;h4>Conclusions&lt;/h4>Genetic mechanisms shared among SCZ, BP, and MDD appear to be related to early neuronal development. Because the genetic architecture of psychopathology transcends diagnostic boundaries, pleiotropy-focused analyses can lead to increased gene discovery and novel insights into relevant pathogenic mechanisms.</pubmed_abstract><journal>Psychological medicine</journal><pubmed_title>Characterizing pleiotropy among bipolar disorder, schizophrenia, and major depression: a genome-wide cross-disorder meta-analysis.</pubmed_title><pmcid>PMC12094657</pmcid><funding_grant_id>RF1 MH132337</funding_grant_id><pubmed_authors>Tylee DS</pubmed_authors><pubmed_authors>De Lillo A</pubmed_authors><pubmed_authors>Pathak GA</pubmed_authors><pubmed_authors>Koller D</pubmed_authors><pubmed_authors>Friligkou E</pubmed_authors><pubmed_authors>Cabrera-Mendoza B</pubmed_authors><pubmed_authors>Polimanti R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Characterizing pleiotropy among bipolar disorder, schizophrenia, and major depression: a genome-wide cross-disorder meta-analysis.</name><description>&lt;h4>Background&lt;/h4>To understand the pathogenetic mechanisms shared among schizophrenia (SCZ), bipolar disorder (BP), and major depression (MDD), we investigated the pleiotropic mechanisms using large-scale genome-wide and brain transcriptomic data.&lt;h4>Methods&lt;/h4>We analyzed SCZ, BP, and MDD genome-wide association datasets available from the Psychiatric Genomics Consortium using the PLEIO framework and characterized the pleiotropic loci identified using pathway and tissue enrichment analyses. Pleiotropic and disorder-specific loci were also assessed.&lt;h4>Results&lt;/h4>Our pleiotropy-informed genome-wide analysis identified 553 variants that included 192 loci not reaching genome-wide significance in input datasets. These were enriched for five molecular pathways: cadherin signaling (&lt;i>p&lt;/i> = 2.18 × 10&lt;sup>-8&lt;/sup>), Alzheimer's disease-amyloid secretase (&lt;i>p&lt;/i> = 4 × 10&lt;sup>-4&lt;/sup>), oxytocin receptor-mediated signaling (&lt;i>p&lt;/i> = 1.47 × 10&lt;sup>-3&lt;/sup>), metabotropic glutamate receptor group III (&lt;i>p&lt;/i&gt; = 5.82 × 10&lt;sup>-4&lt;/sup>) and Wnt signaling (&lt;i>p&lt;/i> = 1.61 × 10&lt;sup>-11&lt;/sup>). Pleiotropic loci demonstrated the strongest enrichment in the brain cortex (&lt;i>p&lt;/i> = 5.8 × 10&lt;sup>-28&lt;/sup>), frontal cortex (&lt;i>p&lt;/i> = 3 × 10&lt;sup>-31&lt;/sup>), and cerebellar hemisphere (&lt;i>p&lt;/i> = 9.8 × 10&lt;sup>-28&lt;/sup>). SCZ-BP-MDD pleiotropic variants were also enriched for neurodevelopmental brain transcriptomic profiles related to the second-trimester post-conception (week 21, &lt;i>p&lt;/i> = 7.35 × 10&lt;sup>-5&lt;/sup>; week 17, &lt;i>p&lt;/i> = 6.36 × 10&lt;sup>-4&lt;/sup>) and first year of life (&lt;i>p&lt;/i> = 3.25 × 10&lt;sup>-5&lt;/sup>).&lt;h4>Conclusions&lt;/h4>Genetic mechanisms shared among SCZ, BP, and MDD appear to be related to early neuronal development. Because the genetic architecture of psychopathology transcends diagnostic boundaries, pleiotropy-focused analyses can lead to increased gene discovery and novel insights into relevant pathogenic mechanisms.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2026-04-08T19:01:01.214Z</modification><creation>2026-04-08T11:27:04.424Z</creation></dates><accession>S-EPMC12094657</accession><cross_references><pubmed>40357923</pubmed><doi>10.1017/S0033291725001217</doi></cross_references></HashMap>